Adrián Gadano

10.1k total citations · 1 hit paper
169 papers, 5.3k citations indexed

About

Adrián Gadano is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Adrián Gadano has authored 169 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Hepatology, 106 papers in Epidemiology and 42 papers in Surgery. Recurrent topics in Adrián Gadano's work include Liver Disease Diagnosis and Treatment (88 papers), Liver Disease and Transplantation (69 papers) and Hepatitis C virus research (57 papers). Adrián Gadano is often cited by papers focused on Liver Disease Diagnosis and Treatment (88 papers), Liver Disease and Transplantation (69 papers) and Hepatitis C virus research (57 papers). Adrián Gadano collaborates with scholars based in Argentina, France and United States. Adrián Gadano's co-authors include Robert G. Gish, Richard Moreau, Didier Lebrec, Anna S. Lok, You‐Chen Chao, Jose D. Sollano, Richard J. Colonno, Kwang‐Hyub Han, Sebastián Marciano and Robert de Man and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Adrián Gadano

166 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

2006 1.1k citations Adrián Gadano et al. profile →

Peers

Countries citing papers authored by Adrián Gadano

Since Specialization

Citations

This map shows the geographic impact of Adrián Gadano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrián Gadano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrián Gadano more than expected).

Fields of papers citing papers by Adrián Gadano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrián Gadano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrián Gadano. The network helps show where Adrián Gadano may publish in the future.

Co-authorship network of co-authors of Adrián Gadano

This figure shows the co-authorship network connecting the top 25 collaborators of Adrián Gadano. A scholar is included among the top collaborators of Adrián Gadano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrián Gadano. Adrián Gadano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group 2025 ·Annals of Hepatology ·Luis Antonio Díaz, (unknown), Francisco Idalsoaga, (unknown), (unknown), Melisa Dirchwolf, (unknown), (unknown), Christopher Valerio, Rodrigo O. Moreira, Mónica Acevedo, Javier Brahm, Nelia Hernández, Adrián Gadano, Cláudia P. Oliveira, Marco Arrese, Graciela Castro‐Narro, Mário Guimarães Pessôa	11
2	Condicionantes de la presencia de glifosato en orina en poblaciones de zonas agroindustriales de la provincia de Buenos Aires, Argentina 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Guillermo Hough, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Adrián Gadano	0
3	HBV elimination in Central and South America: Current status and challenges 2024 ·Clinical Liver Disease ·(unknown), Adrián Gadano	0
4	Enhancing ACLF prediction by integrating sarcopenia assessment and frailty in liver transplant candidates on the waiting list 2023 ·JHEP Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Martín de Santibañes, Sebastián Marciano, Eduardo de Santibáñes, Adrián Gadano, Juan Pekolj, Juan G. Abraldeṣ, Ezequiel Mauro	5
5	Sarcopenia HIBA score predicts sarcopenia and mortality in patients on the liver transplant waiting list 2022 ·Hepatology Communications ·Ezequiel Mauro, Juan Manuel Díaz, (unknown), (unknown), (unknown), (unknown), (unknown), Martín de Santibañes, Juan Pekolj, Eduardo de Santibáñes, Gonzalo Crespo, Juan G. Abraldeṣ, Adrián Gadano	14
6	NAFLD: Challenges and opportunities to address the public health problem in Latin America 2021 ·Annals of Hepatology ·Juan Pablo Arab, Luis Antonio Díaz, Melisa Dirchwolf, Henry E. Mark, Jeffrey V. Lazarus, (unknown), (unknown), Cláudia P. Oliveira, Adrián Gadano, Marco Arrese	25
7	Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype 2021 ·Metabolomics ·(unknown), (unknown), (unknown), Sebastián Marciano, Leila Haddad, (unknown), Paola Casciato, (unknown), (unknown), Margarita Anders, (unknown), (unknown), Marcelo Risk, (unknown), Adrián Gadano, Celia Méndez–García, (unknown), Alberto Penas Steinhardt, (unknown)	15
8	Sarcopenia HIBA score predicts the presence of sarcopenia and mortality in patients on the waiting list for liver transplant 2020 ·Journal of Hepatology ·Ezequiel Mauro, Juan Dı́az, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gonzalo Crespo, (unknown), Adrián Gadano	1
9	Sorafenib for recurrent hepatocellular carcinoma after liver transplantation: a South American experience 2016 ·Redalyc (Universidad Autónoma del Estado de México) ·Federico Piñero, Sebastián Marciano, Margarita Anders, (unknown), Alina Zerega, (unknown), Manuel Mendizábal, (unknown), (unknown), (unknown), Eduardo de Santibáñes, Ricardo Mastaï, Adrián Gadano, Marcelo Silva	3
10	Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina 2015 ·European Journal of Gastroenterology & Hepatology ·Federico Piñero, Sebastián Marciano, Margarita Anders, (unknown), Alina Zerega, (unknown), Oscar Andriani, Eduardo de Santibáñes, (unknown), Luis G. Podestá, Lucas McCormack, Adrián Gadano, Marcelo Silva	18
11	1420 ASUNAPREVIR WITH PEGINTERFERON-ALFA AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE-1 OR -4 CHRONIC HEPATITIS C: SVR24 RESULTS FROM A RANDOMIZED PHASE 2B STUDY (AI447016) 2013 ·Journal of Hepatology ·J.‐P. Bronowicki, Vlad Ratziu, Adrián Gadano, Paul J. Thuluvath, Fernando Bessone, Claudia Martorell, Stanislas Pol, Rubén Terg, Ziad Younes, Bing He, Timothy Eley, David Cohen, Patricia Méndez, Eric Hughes	10
12	Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B 2013 ·Liver Transplantation ·Robert Perrillo, Marı́a Buti, François Durand, Michael Charlton, Adrián Gadano, Guido Cantisani, Che‐Chuan Loong, Kimberly Brown, Wenhua Hu, Juan Carlos López-Talavera, Cyril Llamoso	35
13	[Organ transplants in HIV infected patients. Update and recommendations]. 2011 ·PubMed ·Laura Barcán, Adrián Gadano, (unknown), Federico Villamil	2
14	1177 INTERLEUKIN-28B PREDICTS SVR IN LATIN AMERICAN HEPATITIS C GENOTYPE 1 PATIENTS TREATED WITH PEG IFN AND RIBAVIRIN 2011 ·Journal of Hepatology ·Ezequiel Ridruejo, (unknown), (unknown), (unknown), Sebastián Marciano, Oscar G. Mandό, Omar Galdame, Adrián Gadano, (unknown), Raúl Adrover, Daniel Cocozzella	1
15	841 LONG TERM FOLLOW UP OF PATIENTS TREATED WITH COATED STENTS TIPS 2010 ·Journal of Hepatology ·Juan Carlos Bandi, (unknown), (unknown), Omar Galdame, Ricardo García Mónaco, Adrián Gadano	3
16	The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report 2009 ·Liver International ·(unknown), Antonio Craxı̀, Sanaa M. Kamal, Rami Moucari, Van der Merwe, Samir Haffar, Adrián Gadano, Nizar N. Zein, Ching‐Lung Lai, Jean–Michel Pawlotsky, E. Jenny Heathcote, Geoffrey Dusheiko, Patrick Marcellin	133
17	[517] ETV RE-TREATMENT OF NUCLEOSIDE-NAIVE HBeAg(−) PATIENTS 2007 ·Journal of Hepatology ·Hakan Şentürk, Yoav Lurie, Adrián Gadano, (unknown), (unknown), (unknown), (unknown), Hugo Cheinquer, Jingmao Yang, Ricardo Tamez, R. Hindes	4
18	Polyacrylonitrile Membrane Interposition between a Xenograft and a Patient in Fulminant Liver Failure: The Concept of Xenohemodiafiltration in Clinical Practice 2000 ·ASAIO Journal ·Pablo Argibay, (unknown), (unknown), Juan C Vazquez, Guillermo Rosa-Díez, Juan Pekolj, (unknown), Félix Núñez, Adrián Gadano	4
19	Vascular nitric oxide production during the development of two experimental models of portal hypertension 1999 ·Journal of Hepatology ·Adrián Gadano, Philippe Sogni, (unknown), Richard Moreau, Phuong Nhi Bories, Didier Lebrec	36
20	Hemodynamics after orthotopic liver transplantation: Study of associated factors and long-term effects 1995 ·Hepatology ·Adrián Gadano, Antoine Hadengue, (unknown), Florence Vachiéry, Richard Moreau, Yang Song, Thierry Soupison, Philippe Sogni, Claude Degott, François Durand, Jacques Bernuau, Jacques Belghiti, Serge Erlinger, Jean Pierre Benhamou, Didier Lebrec	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact